OCULAR THERAPEUTIX, INC (OCUL)

Import this data to Google Sheets with:

=jivedata("OCUL","financials")

Full statements spill as a table. For one cell: =jivedata("OCUL","Revenue") or =jivedata("OCUL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

OCULAR THERAPEUTIX, INC

OCUL • CIK 0001393434

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$-82,382	$-171,781	$-270,017	$-313,908
Net Income (Loss) Attributable to Parent	$-80,736	$-193,506	$-265,939	$-301,447
Weighted Average Number of Shares Outstanding, Basic	79,827,362	158,265,162	187,241,483	240,765,107
Weighted Average Number of Shares Outstanding, Diluted	85,596,594	158,265,162	187,241,483	240,765,107
Revenue from Contract with Customer, Excluding Assessed Tax	$58,443	$63,723	$51,951	$52,055
Cost of Goods and Services Sold	$5,281	$5,626	$6,574	$6,708
Research and Development Expense	$61,055	$127,635	$197,096	$223,509
Selling and Marketing Expense	$40,549	$41,590	$53,922	$59,898
General and Administrative Expense	$33,940	$60,653	$64,376	$75,848
Costs and Expenses	$140,825	$235,504	$321,968	$365,963
Investment Income, Net	$3,983	$20,282	$18,355	$22,573
InterestExpenseNonoperating	—	$13,577	$11,835	$11,404
Gain (Loss) on Extinguishment of Debt	$14,190	$-27,950	$-27,950	$-27,950
Other Nonoperating Gains (Losses)	—	—	$29	$29
Nonoperating Income (Expense)	$1,646	$-21,725	$4,078	$12,461

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$195,807	$392,102	$737,060	$598,641
Accounts Receivable, after Allowance for Credit Loss, Current	$26,179	$32,388	$30,650	$30,261
Property, Plant and Equipment, Net	$11,739	$9,389	$19,676	$19,456
Inventory, Net	$2,305	$3,040	$3,564	$3,826
Restricted Cash, Noncurrent	—	$1,614	$1,614	$1,614
Prepaid Expense and Other Assets, Current	$7,794	$13,457	$10,855	$11,699
Operating Lease, Right-of-Use Asset	$6,472	$5,945	$4,638	$5,820
Assets, Current	$232,235	$440,987	$782,129	$644,427
Assets	$252,060	$457,935	$808,057	$671,317
Accounts Payable, Current	$4,389	$4,176	$4,154	$6,996
Accrued Liabilities, Current	$28,666	$35,117	$43,835	$39,056
Contract with Customer, Liability, Current	$255	$128	$128	$64
Operating Lease, Liability, Current	$1,586	$1,933	$2,817	$3,122
Liabilities, Current	$34,896	$41,354	$50,806	$49,174
Operating Lease, Liability, Noncurrent	$6,878	$5,345	$2,815	$3,466
Derivative Liability, Noncurrent	$29,987	$13,246	$13,903	$10,910
Contract with Customer, Liability, Noncurrent	$14,135	$14,000	$14,000	$14,000
Notes Payable, Noncurrent	$65,787	$68,505	$71,336	$72,795
Other Liabilities, Noncurrent	$108	$141	$887	$931
Liabilities	$160,929	$142,591	$153,747	$151,276
Common Stock, Value, Issued	$12	$16	$22	$22
Additional Paid in Capital, Common Stock	$788,697	$1,206,412	$1,811,311	$1,844,417
Retained Earnings (Accumulated Deficit)	$-697,578	$-891,084	$-1,157,023	$-1,324,398
Stockholders' Equity Attributable to Parent	$91,131	$315,344	$654,310	$520,041
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	200,000,000	400,000,000	400,000,000	400,000,000
Common Stock, Shares, Issued	114,963,193	157,749,490	215,927,600	219,589,303

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-80,736	$-193,506	$-265,939	$-301,447
Net Cash Provided by (Used in) Operating Activities	$-70,234	$-134,677	$-204,883	$-238,239
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$93,507	$196,145	$344,958	$207,507
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$197,571	$393,716	$738,674	$1,055,692
Share-based Payment Arrangement, Noncash Expense	$17,825	$33,109	$43,184	$53,281
Payments to Acquire Property, Plant, and Equipment	$6,087	$1,288	$12,010	$16,861
Amortization of Debt Issuance Costs	$6,106	$3,734	$3,397	$3,274
Proceeds from Sale of Property, Plant, and Equipment	—	—	$130	$130
Net Cash Provided by (Used in) Investing Activities	$-6,087	$-1,288	$-11,880	$-16,861
Depreciation, Depletion and Amortization	$2,983	$3,786	$4,323	$5,450
Gain (Loss) on Disposition of Property Plant Equipment	$-1	$-1	$29	$29
Gain (Loss) on Extinguishment of Debt	$14,190	$-27,950	$-27,950	$-27,950
Increase (Decrease) in Accounts Receivable	$4,854	$6,209	$-1,738	$-151
Increase (Decrease) in Prepaid Expense and Other Assets	$3,766	$5,663	$-2,602	$3,225
Proceeds from Notes Payable	$3,722	$82,474	$82,474	$82,474
Increase (Decrease) in Inventories	$331	$735	$524	$787
Proceeds from Stock Options Exercised	$551	$14,741	$20,544	$15,266
Increase (Decrease) in Accounts Payable	$583	$-318	$-887	$1,290
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised	$851	$1,016	$1,592	$1,781
Payments of Financing Costs	$5,184	$5,184	$5,184	$5,184
Increase (Decrease) in Accrued Liabilities	$773	$3,638	$5,248	$582
Sale of Stock, Consideration Received on Transaction	—	—	$539,585	$539,585
Increase (Decrease) in Contract with Customer, Liability	$427	$-262	$-128	$-128
Repayments of Long-term Debt	$26,125	$26,125	$26,125	$26,125
IncreaseDecreaseInOperatingLeaseLiability	$-1,813	$-1,186	$-1,646	$-445
Repayments of Notes Payable	$4,167	$2,000	$2,000	$2,000
Proceeds from Issuance of Private Placement	—	$316,353	$316,353	$316,353
Net Cash Provided by (Used in) Financing Activities	$169,828	$332,110	$561,721	$462,607
Interest Paid, Excluding Capitalized Interest, Operating Activities	$5,464	$21,533	$9,029	$8,944
Capital Expenditures Incurred but Not yet Paid	$16	$121	$1,174	$1,781

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("OCUL","financials")

Full statements spill as a table. For one cell: =jivedata("OCUL","Revenue") or =jivedata("OCUL","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.